Safety Information

Description Publish Date LINKS
Important safety information on Abacavir: Hypersensitivity reaction - educational slide deck 15/02/2024
Important safety information on Cephalosporins in Ethiopia (Safety Notification_Cephalosporins and risk of seizure) 01/03/2023

Important safety information on Cephalosporins in Ethiopia (Safety Notification_Cephalosporins and risk of neurotoxicity)

07/03/2023

Important safety information on Amoxicillin / Amoxicillin and clavulanic acid containing products in Ethiopia

09/09/2023
Important safety information on Cefuroxime sodium in Ethiopia (Safety Notification_Cefuroxime Class 4 Defect MHRA) 30-10-2023
Important safety information on Dolutegravir in Ethiopia (Safety Notification_Korean label update for Dolutegravir containing products) 01-11-2023
Tafenoquine Educational program_TRuST Observational Study_Talking Points 13/10/2023
Tafenoquine Educational program_TRuST_Treatment Schedule for CQ and TQ_1 13/10/2023
Tafenoquine Educational program_TRuST_Treatment Schedule for CQ and TQ_2 13/10/2023
Tafenoquine Educational program_G6PD folder 13/10/2023
Tafenoquine Educational program_Module 4_Unit 1_Quick guide on G6PD testing 13/10/2023
Tafenoquine Educational program_Module 4_Unit 2_Quick guide on G6PD testing 13/10/2023
Tafenoquine Educational program_Module 4_Unit 3_Quick guide on G6PD testing 13/10/2023
Important safety information on Topical Corticosteroids containing products in Ethiopia 15-11-2023
Important safety information on Hepatitis B surface antigen recombinant vaccine in Ethiopia (Initial Safety Notification Engerix-B and Myelitis_November 2023) 17-11-2023
Important safety information on Hepatitis B surface antigen recombinant vaccine in Ethiopia (Updated Safety Notification Engerix-B and Myelitis_December 2023) 02-01-2024

Important safety information on Hepatitis B surface antigen recombinant vaccine (Updated Safety Notification Engerix-B and Myelitis_January 2024)

08/01/2024

Important safety information on Amoxycillin/clavulanate containing products - Amendments to the instructions for medical use of medicines containing amoxicillin/clavulanate, Ukrainian HA website

29/02/2024

Important safety information on Abacavir containing products - Regarding amendments to the instructions for medical use of medicines containing abacavir

19/03/2024

Important safety information on Hepatitis B surface antigen recombinant vaccine - Updated Safety Notification Engerix-B and Myelitis_May 2024

07/05/2024